Find a Doctor

Dr. Gyeong-won D Lee

Gyeongsang National University School Of Medicine

Bio


Gyeong-won Lee is in Chinju, Republic of Korea. Dr. Lee is highly experienced in treating patients with Hiccups. They have been an author on 130 peer reviewed articles and participated in 2 clinical trials in the past 15 years. In particular, they have been an author on 3 peer reviewed articles regarding Hiccups.

Contact

Chinju, KR

Latest Advances


  • Condition: Epstein-Barr Virus-positive, Diffuse Large B Cell Lymphoma
  • Journal: Annals of hematology
  • Treatment Used: Ibrutinib in Combination with Rituximab-cyclophosphamide-doxorubicin Hydrochloride-vincristine Sulfate-prednisone Therapy
  • Number of Patients: 24
  • Published —
In this study, researchers evaluated the outcomes of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone (RCHOP) therapy for the treatment of Epstein-Barr virus-positive, diffuse large B cell lymphoma.
  • Condition: Advanced Marginal Zone Lymphoma
  • Journal: Cancer communications (London, England)
  • Treatment Used: R-CVP (Rituximab, Cyclophosphamide, vincristine and prednisolone) Followed by Rituximab Maintenance Therapy
  • Number of Patients: 45
  • Published —
The purpose of the stuy was to evaluate the survival effectiveness of 2 years of rituximab-maintenance therapy in patients with stage III-IV CD20 positive marginal zone lymphoma who had responded to first-line R-CVP (Rituximab, Cyclophosphamide, vincristine and prednisolone) .
  • Condition: EGFR mutation-positive advanced non-small-cell lung cancer
  • Journal: The Lancet. Oncology
  • Treatment Used: Lazertinib
  • Number of Patients: 127
  • Published —
The study measured the outcomes of using Lazertinib to treat EGFR mutation-positive advanced non-small-cell lung cancer.
  • Condition: Peripheral T-Cell Lymphoma (PTCL)
  • Journal: International journal of hematology
  • Treatment Used: CHOP-Based Chemotherapy
  • Number of Patients: 96
  • Published —
This study determined whether the Glasgow Prognostic Score (GPS) predicts outcomes in patients with peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy.

Contact

Chinju, KR

Insurance

Contact them to find out if they accept your insurance plan.